-
Naturalistic walking in Parkinson’s disease: Prefrontal cortex activity measured with functional near-infrared spectroscopy (fNIRS)
-
Neural Correlates of Dual Task Touchscreen Performance in Parkinson’s Disease
-
Neural oscillatory dynamics in Parkinson disease and dystonia: Insights from EEG analysis
-
Neural Signatures of Laryngeal Dystonia during Asymptomatic Tasks of Sequential and Learned Finger-Tapping
-
Neurocognitive Functioning (NF) in a Patient with Idiopathic Parkinson’s Disease without Dementia (IPDWD). Subjected to Deep Brain Stimulation (DBS) and Treatment by Clinical, Functional and Advanced Neuropsychology.
-
Neurodegeneration with brain iron accumulation in pediatric population: Clinico-radiologic and genetic features
-
Neuroimaging Factors Differentially Associated with Pathology and Clinical Presentation
-
Neuronal Exosome based markers in Parkinson’s Disease and Progressive Supranuclear Palsy
-
Neuropathological Synergy in Cauda Equina Syndrome, Parkinson’s Disease, And Depression: Breaking the Dysphoric Cycle
-
Neuropeptide Alterations in Parkinson’s Disease: A Meta-Analysis
-
Neurophenomenological Aspects of Monocular Visual Hallucinations in Charles Bonnet Syndrome in a patient with Parkinson’s Disease
-
Neurophysiological Underpinnings of Apathy in Parkinson’s Disease Versus Depressive Disorders: A Comparative Study
-
Neuroprotective Action of Betulin in Parkinson’s disease: Alleviating Mitochondrial Dysfunction and Oxidative Stress-Induced Apoptosis in rat model
-
Neuroprotective Action of Exogenous Melatonin in Parkinson Disease Patients and its Impact on Daily Routine: a Systematic Review
-
Neuroprotective Effect of Isoquercitrin in Rotenone Induced Parkinson’s Disease-Like Motor and non-motor Symptoms in Zebrafish
-
Neuroprotective Efficacy of Ethanolic Extract from Amorphophallus Paeoniifolius Tuber Against Haloperidol-Induced Parkinson’s Disease Model
-
Neuroprotective role of baicalein via autophagy mediated modulation of associated motor proteins in experimental animals of Parkinson disease
-
Neuropsychiatric Manifestations in Patients with Degenerative Cerebellar Ataxias from Serbia
-
Neuropsychiatric symptoms in patients with probable Progressive supranuclear palsy in reference centers of Valle del Cauca- Colombia
-
Neuropsychiatric symptoms in sporadic Creutzfeldt-Jakob disease
-
Neuropsychological Predictors of Cognitive Decline in Parkinson’s Disease: A Systematic Review (PDCogniCare)
-
Neuropsychological Tests of Language, Memory, and Visuospatial Function in Parkinson’s Disease: Review, Critique and Recommendations
-
Neurotinib, a Brain Penetrant c-Abl Inhibitor, Prevents Activation and Phosphorylation of c-Abl Kinase and Alpha-Synuclein
-
Neurovascular Involvement in Parkinson’s Disease Cognitive Impairment: A 4D Flow Study
-
New onset movement disorders following COVID-19 infection
-
New Pathological Findings in an International Cohort of Hereditary Spastic Paraplegia 4 Patients
-
New α-Synuclein Strain Biomarker in Parkinson’s Disease and Related Dementia
-
NGS diagnosis rate in a combined cerebellar ataxia and spastic paraplegia series from southern Spain
-
Nigral Neuroinflammation and Dopaminergic Neurons in PD, MSA and PSP: A Comparative Clinicopathological Study
-
No Association between Anemia and Risk of Parkinson’s Disease: Evidence From A Meta-Analysis Using Real-World Evidence
-
Nocturnal Blood Pressure, Non-Dipping, Psychosis And Non-Motor Symptoms In Early Stages Of Huntington’s Disease Patients
-
Nocturnal Bradykinesia is better detected using wearable sensors in Parkinson’s disease compared to clinical outcome
-
Nocturnal Hypertension in Parkinson’s Disease. The Flip Side of a Tainted Coin
-
Nocturnal Use of Add-On Medications for Parkinson’s Disease: Post Hoc Analysis of the COSMOS Study
-
Non Classified Spinocerebellar Ataxia-like Syndrome due to GYG-1 gene mutation with TPM3, GEMIN5 and DES mutations in a Peruvian family
-
Non motor symptoms assessment in Primary Familial Brain Calcification, survey on a cohort
-
Non-interventional phase 0 study for the collection of biospecimens from patients with Parkinson’s Disease (PD) to support the development of a diagnostic classifier for LRRK2-driven PD
-
Non-invasive transcranial Eectrical Stimulation (tRNS and tACS) targeting the Pallidum in normal Controls and PD Patients by rotating electrical Fields
-
Non-Motor Symptoms and Comorbidities in a Cohort of Puerto Rican Parkinson’s Disease: Do They Affect Severity and Progression?
-
Non-motor Symptoms and Quality-of-life of People with Parkinson’s disease
-
Non-motor symptoms in people with Huntington’s disease: use and validation of the MDS Non-Motor Scale (MDS-NMS)
-
Nonmotor symptoms in Spinocerebellar ataxia type 12 (SCA 12)
-
Noradrenaline treatment of apathy and impulsivity in participants with Progressive Supranuclear Palsy syndromes (NORAPS). A Phase II clinical trial – ISRCTN99462035.
-
Normal pressure hydrocephalus in two Parkinson’s disease patients with deep brain stimulation – co-occurrence or complication
-
NouvNeu001, A Phase 1 Stage Chemically Induced Human Dopaminergic Progenitor Cell Therapy for the Treatment of Mid- to Late-stage Parkinson’s Disease
-
Novel ASO Targeting IGHMBP2 Cryptic Splice Variant: Efficacy and Safety
-
Novel In-Clinic Use of Levodopa Inhalation Powder (CVT-301) as an Outpatient Diagnostic Tool for Parkinson’s Disease
-
Novel Partial Gene Deletion in CaCNA1A Presenting with Gait Ataxia, Vertigo, and Abnormal Eye Movements
-
Nutritional Status Implication at 6 Months in Parkinson’s Disease: Follow-Up Results
2024 International Congress
September 27-October 1, 2024. Philadelphia, PA.